| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC3069 |
| Trial ID | NCT05415475 |
| Disease | Stomach Cancer | Pancreatic Cancer | Esophageal Cancer | Colorectal Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC034 |
| Cohort1: Intravenous infusion | |||||||||
|
|||||||||
| Cohort2: Intraperitoneal injection | |||||||||
|
|||||||||